0
How Can We Learn About Developmental Processes From Cross-Sectional Studies, or Can We?
Helena Chmura Kraemer, Ph.D.,; Jerome A. Yesavage, M.D.,; Joy L. Taylor, Ph.D.,; David Kupfer, M.D.
Late-Onset Schizophrenia and Very-Late-Onset Schizophrenia-Like Psychosis: An International Consensus
Robert Howard, M.D.,; Peter V. Rabins, M.D., M.P.H.,; Mary V. Seeman, M.D.,; Dilip V. Jeste, M.D.,; the International Late-Onset, Schizophrenia Group
Risk of Recurrence of Bipolar Disorder in Pregnant and Nonpregnant Women After Discontinuing Lithium Maintenance
Adele C. Viguera, M.D.; Ruta Nonacs, M.D.; Lee S. Cohen, M.D.; Leonardo Tondo, M.D.; Aoife Murray, A.B.; Ross J. Baldessarini, M.D.
Paroxetine in Human Breast Milk and Nursing Infants
Zachary N. Stowe, M.D.; Lee S. Cohen, M.D.; Amy Hostetter, B.A.; James C. Ritchie, Ph.D.; Michael J. Owens, Ph.D.; Charles B. Nemeroff, M.D., Ph.D.
Further Evidence of Relation Between Prenatal Famine and Major Affective Disorder
Alan S. Brown, M.D.; Jim van Os, M.D., Ph.D.; Corine Driessens; Hans W. Hoek, M.D., Ph.D.; Ezra S. Susser, M.D., Dr.P.H.
Phenomenology and Outcome of Subjects With Early- and Adult-Onset Psychotic Mania
Gabrielle A. Carlson, M.D.; Evelyn J. Bromet, Ph.D.; Sylvia Sievers, M.A.
Two-Year Syndromal and Functional Recovery in 219 Cases of First-Episode Major Affective Disorder With Psychotic Features
Mauricio Tohen, M.D., Dr.P.H.; John Hennen, Ph.D.; Carlos M. Zarate, Jr., M.D.; Ross J. Baldessarini, M.D.; Stephen M. Strakowski, M.D.; Andrew L. Stoll, M.D.; Gianni L. Faedda, M.D.; Trisha Suppes, M.D., Ph.D.; Priscilla Gebre-Medhin, M.S.; Bruce M. Cohen, M.D., Ph.D.
Multiple Recurrences of Major Depressive Disorder
David A. Solomon, M.D.; Martin B. Keller, M.D.; Andrew C. Leon, Ph.D.; Timothy I. Mueller, M.D.; Philip W. Lavori, Ph.D.; M. Tracie Shea, Ph.D.; William Coryell, M.D.; Meredith Warshaw, M.S.S., M.A.; Carolyn Turvey, Ph.D.; Jack D. Maser, Ph.D.; Jean Endicott, Ph.D.
Lack of Seasonal Mood Change in the Icelandic Population: Results of a Cross-Sectional Study
Andres Magnusson, M.D.; Johann Axelsson, D.Phil.; Mikael M. Karlsson, Ph.D.; Högni Oskarsson, M.D.
Female Sexual Dysfunction Associated With Antidepressant Administration: A Randomized, Placebo-Controlled Study of Pharmacologic Intervention
David Michelson, M.D.; John Bancroft, M.D.; Steven Targum, M.D.; Yongman Kim, Ph.D.; Rosalinda Tepner, R.Ph.
Impact of Psychiatric Conditions on Health-Related Quality of Life in Persons With HIV Infection
Cathy D. Sherbourne, Ph.D.; Ron D. Hays, Ph.D.; John A. Fleishman, Ph.D.; Benedetto Vitiello, M.D.; Kathryn M. Magruder, Ph.D.; Eric G. Bing, M.D., M.P.H.; Dan McCaffrey, Ph.D.; Audrey Burnam, Ph.D.; Doug Longshore, Ph.D.; Ferd Eggan, M.A.; Samuel A. Bozzette, M.D., Ph.D.; Martin F. Shapiro, M.D., Ph.D.
Auditory Startle Response in Trauma Survivors With Posttraumatic Stress Disorder: A Prospective Study
Arieh Y. Shalev, M.D.; Tuvia Peri, Ph.D.; Dalia Brandes, M.A.; Sara Freedman, M.Sc.; Scott P. Orr, Ph.D.; Roger K. Pitman, M.D.
Asperger’s Disorder
Fred R. Volkmar, M.D.; Ami Klin, Ph.D.; Robert T. Schultz, Ph.D.; Emily Rubin, M.S., C.C.C.-S.L.P.; Richard Bronen, M.D.
Striatal Dopamine Transporter Binding in Neuroleptic-Naive Patients With Schizophrenia Studied With Positron Emission Tomography
Aki Laakso, M.D., Ph.D.; Harry Vilkman, M.D.; Birgitta Alakare, M.D.; Merja Haaparanta, M.Sc.; Jörgen Bergman, M.Sc.; Olof Solin, Ph.D.; Jari Peurasaari, M.D.; Viljo Räkköläinen, M.D., Ph.D.; Erkka Syvälahti, M.D., Ph.D.; Jarmo Hietala, M.D., Ph.D.
Genetic Influence on Laterality in Schizophrenia? A Twin Study of Neurological Soft Signs
Rainer Niethammer, M.D.; Matthias Weisbrod, M.D.; Steffi Schiesser, M.D.; Jo Grothe, Ph.D.; Sabine Maier, Ph.D.; Uta Peter, Ph.D.; Claudia Kaufmann, Ph.D.; Johannes Schröder, M.D.; Heinrich Sauer, M.D.
Verbal Working Memory Impairment in Schizophrenia Patients and Their First-Degree Relatives: Evidence From the Digit Span Task
Heather M. Conklin, B.S.; Clayton E. Curtis, Ph.D.; Joanna Katsanis, Ph.D.; William G. Iacono, Ph.D.
Alterations in the Functional Anatomy of Working Memory in Adult Attention Deficit Hyperactivity Disorder
Julie B. Schweitzer, Ph.D.; Tracy L. Faber, Ph.D.; Scott T. Grafton, M.D.; Larry E. Tune, M.D., M.P.H.; John M. Hoffman, M.D.; Clinton D. Kilts, Ph.D.
MRI Assessment of Children With Obsessive-Compulsive Disorder or Tics Associated With Streptococcal Infection
Jay N. Giedd, M.D.; Judith L. Rapoport, M.D.; Marjorie A. Garvey, M.D.; Susan Perlmutter, M.D.; Susan E. Swedo, M.D.
Altered cAMP-Dependent Protein Kinase A in Platelets of Patients With Obsessive-Compulsive Disorder
Jorge Perez, M.D., Ph.D.; Daniela Tardito, Ph.D.; Luigi Ravizza, M.D.; Giorgio Racagni, Ph.D.; Silvia Mori, Ph.D.; Giuseppe Maina, M.D.
Use of the Selective Serotonin 3 Receptor Antagonist Ondansetron in the Treatment of Neuroleptic-Induced Tardive Dyskinesia
Pinkhas Sirota, M.D.; Tanya Mosheva, M.D.; Hertzel Shabtay, M.D.; Nir Giladi, M.D.; Amos D. Korczyn, M.D., M.Sc.
Prediction of Detached Personality in Healthy Subjects by Low Dopamine Transporter Binding
Aki Laakso, M.D., Ph.D.; Harry Vilkman, M.D.; Jaana Kajander, M.D.; Jörgen Bergman, M.Sc.; Merja Haaparanta, M.Sc.; Olof Solin, Ph.D.; Jarmo Hietala, M.D., Ph.D.
Bright Light Therapy’s Effect on Postpartum Depression
MARIA CORRAL, M.D., F.R.C.P.C.; ANNIE KUAN, B.A.; DEMETRA KOSTARAS, B.SC., M.A.
Risperidone Treatment for Psychosis in End-Stage Friedreich’s Ataxia
MATT J. SALBENBLATT, M.D.; RANDALL D. BUZAN, M.D.; STEVEN L. DUBOVSKY, M.D.
Dextromethorphan-Induced Psychosis
LAWRENCE H. PRICE, M.D.; JACQUELINE LEBEL, J.D., M.D.
Intoxication With Olanzapine
RALPH F. BOSCH, M.D.; ANDREAS BAUMBACH, M.D.; MICHAEL BITZER, M.D.; CHRISTIANE M. ERLEY, M.D.
Conflicted Caregivers
EDMUND F. KAL, M.D.
Cost-Effectiveness of Psychiatrists
DEBORAH A. ZARIN, M.D.; JOYCE C. WEST, PH.D., M.P.P.
Dr. Stotland Replies
NADA L. STOTLAND, M.D., M.P.H.
Cost-Effectiveness of Psychiatrists
JOHN C. MARKOWITZ, M.D.; NORMAN A. CLEMENS, M.D.; GLEN O. GABBARD, M.D.
Dr. Dewan Replies
MANTOSH DEWAN, M.D.
Magnetic Resonance Imaging Abnormalities and Psychiatric Illness
SARAH GARSIDE, PH.D., M.D.; PATRICIA I. ROSEBUSH, M.SC.N., M.D., F.R.C.P.(C.); ANTHONY J. LEVINSON, M.D.; MICHAEL F. MAZUREK, M.D., F.R.C.P.(C.)
Cognitive Effects of Testosterone Supplementation
MARK J. SMITH, M.D., PH.D.; PETER J. SCHMIDT, M.D.; DAVID R. RUBINOW, M.D.
Dr. Ahearn and Colleagues Reply
EILEEN P. AHEARN, M.D., PH.D.; DAVID C. STEFFENS, M.D.; FREDERICK CASSIDY, M.D.; SUSAN VAN METER, M.D.; JAMES M. PROVENZALE, M.D.; RICHARD H. WEISLER, M.D.; K. RANGA RAMA KRISHNAN, M.D.
Dr. Sternbach Replies
HARVEY STERNBACH, M.D.
Drs. Westen and Shedler Reply
DREW WESTEN, PH.D.; JONATHAN SHEDLER, PH.D.
Comparison of Clozapine and Risperidone
ROBERT M. HAMER, PH.D.; PIPPA M. SIMPSON, PH.D.
Sympathoadrenal Hyperactivity and Neuroleptic Malignant Syndrome
NASEEM AKHTAR QURESHI, M.D.; TARIQ ALI AL-HABEEB, K.S.U.F.
Dr. Gurrera Replies
RONALD J. GURERRA, M.D.